Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples